Calidi Biotherapeutics, Inc. (CLDI)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-529.6%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | $45.0K | — |
| Operating Income | -$20.24M | -$21.78M | -$28.99M | -$23.13M | — |
| Net Income | -$19.91M | -$22.14M | -$29.22M | -$25.43M | — |
| EPS (Diluted) | $-5.95 | $-35.70 | $-17.33 | $2.99 | — |
| Total Assets | $8.86M | $14.18M | $10.02M | $2.60M | $231.77M |
| Total Liabilities | $5.10M | $12.21M | $18.25M | $43.44M | $16.45M |
| Shareholders' Equity | $3.76M | $1.53M | -$8.23M | -$50.44M | -$31.61M |
| Cash & Equivalents | — | $9.60M | — | — | $1.06M |
| Operating Cash Flow | -$21.29M | -$19.69M | -$26.98M | -$13.21M | — |
| Shares Outstanding | 7.22M | 1.73M | 3.55M | 8.58M | 23.00M |